AnalystsKen CacciatoreKen Cacciatore's Stock Forecasts
AnalystsKen Cacciatore
Analyst Ranking
Bottom 9%
#3844 out of 4174 analysts
Average Return
-21.82%
Win Rate
40%4 out of 10
Risk vs Reward
Poor
Good
Ken Cacciatore's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Biohaven Pharmaceutical Holding Co LtdBHVN1 | +93.70% | $38.41 | $74.40 | 2020-04-16 - 2021-04-16 | Buy |
Scpharmaceuticals IncSCPH | +8.01% | $7.12 | $7.69 | 2022-11-30 - 2023-02-06 | Buy |
Takeda Pharmaceutical Co LtdTAK | +7.78% | $14.66 | $15.80 | 2022-07-18 - 2023-02-06 | Buy |
Bausch & Lomb CorpBLCO | +3.99% | $16.55 | $17.21 | 2022-05-10 - 2023-02-06 | Buy |
Ken Cacciatore Analyst Color
Get additional color on Ken Cacciatore's coverage of popular stocks
Ken Cacciatore's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Scpharmaceuticals IncSCPH | 1 | Buy | $25.00 | +225.10% | Initiates Coverage On | 2 months ago |
Takeda Pharmaceutical Co LtdTAK | 1 | Buy | $24.00 | +51.90% | Upgrades | 7 months ago |
Bausch & Lomb CorpBLCO | 1 | Buy | $35.00 | +103.37% | Initiates Coverage On | 9 months ago |
Molecular Partners AgMOLN | 1 | Buy | $50.00 | N/A | Initiates Coverage On | 2 years ago |
Arcutis Biotherapeutics IncARQT | 1 | Buy | $80.00 | N/A | Maintains | 2 years ago |
Protara Therapeutics IncTARA | 1 | Buy | $50.00 | N/A | Initiates Coverage On | 2 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 1 | Buy | $45.00 | N/A | Initiates Coverage On | 3 years ago |
Amarin Corp PLCAMRN | 1 | Buy | $23.00 | N/A | Initiates Coverage On | 3 years ago |
Iveric Bio IncISEE | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 3 years ago |
Optinose IncOPTN | 1 | Buy | $25.00 | N/A | Initiates Coverage On | 3 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.